Montega reiterates Buy on AlzChem, sets EUR 220 price target

Reuters2026/07/30 15:18

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Montega reiterated a Buy rating on AlzChem, keeping its 12-month price target at EUR 220.
Q2 revenue rose 8.7% year over year to EUR 155.3 million, beating Montega’s EUR 147 million estimate.
Q2 EBITDA increased 10.7% to EUR 32.2 million, despite pressure in Basics & Intermediates.
Guidance stayed unchanged at about EUR 600 million revenue, about EUR 126 million EBITDA.
Montega flagged capacity expansion progress, including a nitroguanidine ramp-up in Germany starting in H2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26340) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Montega reiterates Buy on AlzChem, sets EUR 220 price target

You may also like

Crypto prices